As a leader amongst your peers, nothing is more important than patient safety. In today’s pay for performance environment managing risk, resources and complexity isn’t optional, it’s mandatory.
CQuentia’s Perioperative Pharmacogenomic testing program provides the patients unique individual genetic profile identifying how the patient will respond to the various medications used during and after surgery. The results of which are delivered directly into your EMR system. CQuentia also defines when a patient has a genetic risk for malignant hyperthermia, a pseudocholinesterase deficiency, or has a thrombosis risk. This combined view of medication efficacy and risk factors provides a greater level of patient detail that directly impacts the success of the surgical event. PGx guided medication management has shown to reduce narcotic use during surgery, decrease instances of post-operative side effects (such as nausea/vomiting) and improve post-operative pain scores.
Find out what Dr. Thomas Hamelin, DNP, MBA, RN, NEA-BC, has to say about working with CQuentia.
Contact us to enlist your institution in a no-risk trial of our PGx program and be our partner in improving global health care by accelerating the impact of genomics on patient care.
CQuentia, more than a lab, more than a test. We put you on the frontline of the new frontier of genomic testing and personalized medicine.